AAAAAA

   
Results: << | 101-125 | 126-150 | 151-175 | 176-200 | >>
Results: 101-125/258

Authors: GOODACRE AM CLODI K GRACE C YOUNES A CABANILLAS F ANDREEFF M
Citation: Am. Goodacre et al., COMPARATIVE GENOMIC HYBRIDIZATION (CGH) REDEFINES DELETION 6Q IN LYMPHOID MALIGNANCIES, Blood, 88(10), 1996, pp. 3294-3294

Authors: CLODI K YOUNES A GOODACRE A ROBERTS M PALMER J YOUNES M CABANILLAS F ANDREEFF M
Citation: K. Clodi et al., P53 GENE DELETIONS IN NON-HODGKINS-LYMPHOMA DETERMINED BY DUAL-COLOR FLUORESCENCE IN-SITU HYBRIDIZATION, Blood, 88(10), 1996, pp. 3455-3455

Authors: KANTARJIAN H OBRIEN S BERAN M GIRALT S ESTEY E KOLLER C KORNBLAU S ANDREEFF M DEVOS D KEATING M TALPAZ M
Citation: H. Kantarjian et al., RESULTS WITH DECITABINE, A HYPOMETHYLATING AGENT, IN THE TREATMENT OFCHRONIC MYELOGENOUS LEUKEMIA (CML) IN ACCELERATED OR ELASTIC PHASES, Blood, 88(10), 1996, pp. 3522-3522

Authors: MARINI FC ZHANG X TRAPNELL B ANDREEFF M
Citation: Fc. Marini et al., INEFFICIENT INFECTION OF PRIMITIVE HEMATOPOIETIC PRECURSORS CELLS (CD34-V)() USING CMV DRIVEN ADENOVIRAL VECTORS (AD), Blood, 88(10), 1996, pp. 3896-3896

Authors: JIANG S KONOPLEVA M BSEISO A ZHAO S ANDREEFF M
Citation: S. Jiang et al., ISOTYPE CONVERSION OF CD45RA TO CD45RO AS AN EARLY EVENT IN ARA-C INDUCED APOPTOSIS OF ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) CELLS, Blood, 88(10), 1996, pp. 256-256

Authors: ZHAO S LING YH SNELL V ZHANG X REED JC PEREZSOLER R ANDREEFF M
Citation: S. Zhao et al., SENSITIZATION TO THE CYTOTOXIC EFFECT OF TOPOISOMERASE-1 INHIBITORS IN BAX TRANSFECTION OF LYMPHOBLASTIC-LEUKEMIA, Blood, 88(10), 1996, pp. 267-267

Authors: SCHENK TM KEYHANI A KLICHE KO KANTARJIAN H ANDREEFF M
Citation: Tm. Schenk et al., MULTILINEAGE INVOLVEMENT IN ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - NEW EVIDENCE FOR STEM-CELL ALL BY INTERPHASE FISH, Blood, 88(10), 1996, pp. 287-287

Authors: ANDREEFF M ZHAO S KLICHE KO JIANG S CONSOLI U LISOVSKY M SNELL V ZHANG X SANCHEZWILLIAMS G REED J ESTEY E
Citation: M. Andreeff et al., REGULATION OF APOPTOSIS IN NORMAL HEMATOPOIESIS AND IN MYELOID LEUKEMIAS, Blood, 88(10), 1996, pp. 314-314

Authors: FLEMING R ESTEY E KANTARJIAN H OBRIEN S KEATING M BERAN M KORNBLAU S FREIREICH E ANDREEFF M CORTES J VASSILAKI M TURAN A RISSER J LUNA M ANAISSIE E
Citation: R. Fleming et al., INVASIVE ASPERGILLOSIS DURING INDUCTION THERAPY FOR ACUTE-LEUKEMIA - PREDISPOSING AND PROGNOSTIC FACTORS, Blood, 88(10), 1996, pp. 319-319

Authors: KONOPLEVA M ESTROV Z ANDREEFF M METHA K
Citation: M. Konopleva et al., CELL-SURFACE ANTIGEN CD38 INDUCES A CELL-GROWTH SIGNAL IN LEUKEMIC-CELLS, Blood, 88(10), 1996, pp. 335-335

Authors: MELNYK A THERIAULT R ANDREEFF M SANSORESGARCIA L PHILLIPS MD
Citation: A. Melnyk et al., FACTOR-V LEIDEN (G1691A) AND THE RISK OF THROMBOSIS IN PATIENTS WITH SOLID TUMORS - A PROSPECTIVE CASE-CONTROL STUDY, Blood, 88(10), 1996, pp. 592-592

Authors: SARRIS AH KLICHE KO SMITH T PRETI A MESSINA O HESS M PUGH W ANDREEFF M CABANILLAS F
Citation: Ah. Sarris et al., ELEVATED SERUM IL-10 - AN ADVERSE PROGNOSTIC FACTOR FOR FAILURE-FREE SURVIVAL (FFS) IN ADULTS WITH ADVANCED HODGKINS-DISEASE (HD), Blood, 88(10), 1996, pp. 894-894

Authors: CORTES J KANTARJIAN H OBRIEN S BERAN M ESTEY E KOLLER C ANDREEFF M KORNBLAU S KEATING M FREIREICH EJ TALPAZ M
Citation: J. Cortes et al., SUPPRESSION OF CLONAL EVOLUTION IN PATIENTS WITH PHILADELPHIA-CHROMOSOME (PH)-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA (CML) ON INTERFERON-ALFA THERAPY (IFN-A) THERAPY, Blood, 88(10), 1996, pp. 918-918

Authors: BSEISO AW JIANG S KANTARJIAN H CHAMPLIN R TALPAZ M ANDREEFF M
Citation: Aw. Bseiso et al., DECREASED EXPRESSION OF CD45RO ON PRIMITIVE HEMATOPOIETIC PROGENITOR CELLS (HPC) IN CHRONIC MYELOGENOUS LEUKEMIA (CML), Blood, 88(10), 1996, pp. 923-923

Authors: YOUNES A SNELL V CONSOLI U CLODI K THOMAS EK ANDREEFF M
Citation: A. Younes et al., CD40 LIGAND RESCUES CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) CELLS FROM SPONTANEOUS APOPTOSIS AND MEDIATES RESISTANCE TO FAS LIGAND AND FLUDARABINE, Blood, 88(10), 1996, pp. 931-931

Authors: KAVANAGH J HANANIA E GILES R FU SQ ZU Z ELLERSON D WANG T CLAXTON D RAHMAN Z BERENSON R HEIMFELD S COTE R HOLZMAYER T MECHETNER E DAYNE A ANDREEFF M CHAMPLIN R DEISSEROTH AB
Citation: J. Kavanagh et al., GENETIC-MODIFICATION OF CELLS USED FOR TRANSPLANT FOLLOWING INTENSIVETHERAPY FOR OVARIAN-CANCER ANP BREAST-CANCER, Blood, 88(10), 1996, pp. 1075-1075

Authors: MARINI FC ZHANG X TRAPNELL B ANDREEFF M
Citation: Fc. Marini et al., BONE-MARROW PURGING OF RESIDUAL BREAST-CANCER BY ADENOVIRAL TRANSFER OF THE HSV-TK GENE, Blood, 88(10), 1996, pp. 1076-1076

Authors: JURECIC R NACHTMAN RG JIANG S SNELL V ANDREEFF M BELMONT JW
Citation: R. Jurecic et al., HIGH-THROUGHPUT READOUT OF DIFFERENTIAL GENE-EXPRESSION IN HUMAN HEMATOPOIETIC STEM-CELLS AND PROGENITORS USING LONG-DISTANCE DD-PCR AND CDNA SEQUENCING, Blood, 88(10), 1996, pp. 1337-1337

Authors: FAYAD L KANTARJIAN H OBRIEN S BERAN M KOLLER C KORNBLAU S ANDREEFF M ESTEY E KEATING M FREIREICH E
Citation: L. Fayad et al., SIGNIFICANCE OF DAY 7 (D7) PERSISTENCE OR PERIPHERAL BLASTS (PBB) GREATER-THAN-0, AND DAY 14 (D14) PERSISTENCE OF BONE-MARROW BLASTS (BMB) GREATER-THAN-5-PERCENT IN ADULT ACUTE LYMPHOCYTIC-LEUKEMIA (ALL) ACCORDING TO TREATMENT INTENSITY, Blood, 88(10), 1996, pp. 1483-1483

Authors: GOODACRE AM LUTHRA R CLODI K GRACE C YOUNES A CABANILLAS F PUGH W ANDREEFF M
Citation: Am. Goodacre et al., PARTIAL TRISOMY OF 3Q21QTER IS A CONSISTENT ABNORMALLY IN MANTLE CELLLYMPHOMA IDENTIFIED BY COMPARATIVE GENOMIC HYBRIDIZATION (CGH), Blood, 88(10), 1996, pp. 1519-1519

Authors: SNELL V CLODI K GOODWIN R KADIN M CABANILLAS F ANDREEFF M YOUNES A
Citation: V. Snell et al., BIOLOGIC ACTIVITY OF THE TNF-RELATED APOPTOSIS-INDUCING LIGAND (TRAIL) AGAINST FRESH HUMAN LYMPHOID MALIGNANCIES AND CELL-LINES, Blood, 88(10), 1996, pp. 1526-1526

Authors: BACHIER C GILES RE ELLERSON D HANANIA EG GARCIASANCHEZ F HALEY T ANDREEFF M CABANILLAS F CHAMPLIN R BERENSON R HEIMFELD S DEISSEROTH AB
Citation: C. Bachier et al., RETROVIRAL GENE MARKING TO IDENTIFY THE ORIGIN OF RELAPSE FOLLOWING AUTOLOGOUS CD34 POSITIVE BONE-MARROW (BM) AND PERIPHERAL-BLOOD (PB) TRANSPLANTATION IN FOLLICULAR NONHODGKINS LYMPHOMA (FNHL), Blood, 88(10), 1996, pp. 1707-1707

Authors: ESTEY E BERAN M HAYES K LOVSHE D KOMBLAU S PIERCE S KOLLER C OBRIEN S KANTARJIAN H ANDREEFF M KEATING M FREIREICH E
Citation: E. Estey et al., CYTOGENETIC (CG) AND FLUORESCENT IN-SITU HYBRIDIZATION (FISH) ANALYSIS ON COURSE 1 DAY 21 OF CHEMOTHERAPY (CT) FOR NEWLY-DIAGNOSED AML MDS/, Blood, 88(10), 1996, pp. 2245-2245

Authors: HANANIA E GILES R FU SQ ZU Z COTE R DAYN A WANG T ELLERSON D KAVANAGH J HOLZMAYER T MECHETNER E BERENSON R HEIMFELD S RAHMAN Z ANDREEFF M CHAMPLIN R DEISSEROTH AB
Citation: E. Hanania et al., MDR-1 VECTOR MARKING SHOWS THAT CFUGMS DO NOT CONTRIBUTE TO ENGRAFTMENT IN PATIENTS FOLLOWING INTENSIVE SYSTEMIC COMBINATION CHEMOTHERAPY, Blood, 88(10), 1996, pp. 2369-2369

Authors: KLICHE KO ANDREEFF M
Citation: Ko. Kliche et M. Andreeff, HYPERAPOPTOSIS AS PATHOPHYSIOLOGIC BASIS OF MYELODYSPLASTIC SYNDROMES(MDS), Blood, 88(10), 1996, pp. 2545-2545
Risultati: << | 101-125 | 126-150 | 151-175 | 176-200 | >>